Immunic Inc. buy Roth Capital
Start price
07.11.25
/
50%
€0.60
Target price
07.11.26
€2.60
Performance (%)
-3.68%
Price
05.12.25
€0.58
Summary
This prediction is currently active. With a performance of -3.68%, the BUY prediction by Roth_Capital is trending in the wrong direction. This prediction currently runs until 07.11.26. The prediction end date can be changed by Roth_Capital at any time. Roth_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Immunic Inc. | -6.341% | -6.341% |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by Roth_Capital for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat